Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
How this reality TV show helps competing entrepreneurs find their people — not just adversaries
It’s five days, 14-hour workdays, and one intense experience aimed at helping entrepreneurs sharpen their businesses. The setup for The Blox — a startup-focused reality TV competition and bootcamp — is crafted to immerse builders in the rigors of real-world business, said Weston Bergmann. Season 17 of the live-in competition show launched in June, emphasizing…
C2FO named top fintech by CNBC; leaders celebrate win, pushing toward $500B funding milestone
A Kansas City fintech’s award-winning efforts to boost working capital access for businesses across the globe not only has built trust among the world’s top enterprises, said Sandy Kemper; it’s positioned C2FO for even greater impact as it transforms the financing landscape for previously overlooked ventures. The company was honored this month as one of…
Bar K dog bar closes all locations, calling out KC riverfront construction, rising inflation
Owners of the award-winning Bar K dog bar — a popular destination for four-legged Kansas Citians and their friends — announced its closure Tuesday, after nearly a decade in business that saw the concept expand to St. Louis and Oklahoma City before suddenly shuttering all operations. “We are heartbroken to announce that Bar K will be…
Months after taking over century-old tailor shop, owner putts his new golf apparel brand in play
Even when an entrepreneur hyper-obsesses over the details, Michael Jerwick learned, opportunity isn’t always tailor-fit to the most conveniently designed timing. The Slabotsky’s owner just transplanted his century-spanning family business to River Market — a mere week before launching a brand new apparel side project. Two of the biggest moves of his career, Jerwick had…